---
title: "Shandong Boan Biotech enters RMB 75 million sale-and-leaseback deal with Industrial Bank Financial Leasing"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297202959.md"
description: "Shandong Boan Biotech signed a RMB 75 million sale-and-leaseback deal with Industrial Bank Financial Leasing on Aug 27, 2026. The transaction funds working capital, with the company repaying RMB 79.85 million over 36 months. This deal aggregates with a January 2026 lease, constituting a disclosable transaction under Hong Kong listing rules."
datetime: "2026-08-27T14:34:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297202959.md)
  - [en](https://longbridge.com/en/news/297202959.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297202959.md)
generator: "portal-rs"
---

# Shandong Boan Biotech enters RMB 75 million sale-and-leaseback deal with Industrial Bank Financial Leasing

-   Shandong Boan Biotechnology entered a sale-and-leaseback with Industrial Bank Financial Leasing for machinery and equipment on Aug. 27, 2026. \* Industrial Bank Financial Leasing will pay RMB 75 million to buy the assets, funding working capital. \* The company will pay about RMB 79.85 million over 36 months in 12 quarterly installments, including about RMB 4.85 million interest. \* Legal title transfers to the lessor during the lease, with a RMB 1 repurchase at maturity. \* Deal aggregates with a January 2026 lease, making it a discloseable transaction under Hong Kong listing rules. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shandong Boan Biotechnology Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260827-12303507), on August 27, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [06955.HK](https://longbridge.com/en/quote/06955.HK.md)
- [601166.CN](https://longbridge.com/en/quote/601166.CN.md)
- [00388.HK](https://longbridge.com/en/quote/00388.HK.md)
- [80388.HK](https://longbridge.com/en/quote/80388.HK.md)
- [HKXCY.US](https://longbridge.com/en/quote/HKXCY.US.md)

## Related News & Research

- [Shandong Boan Biotech says China CDE accepts IND filing for BA2201 bispecific antibody](https://longbridge.com/en/news/297032709.md)
- [Shandong Boan Biotech files HKEX next-day return disclosing share buyback at HKD 3.74 each](https://longbridge.com/en/news/297320356.md)
- [08:00 ETMinistry of Food and Drug Safety of Korea, Successfully Concludes 'GBC 2026,' Marking a Great Leap in Bio](https://longbridge.com/en/news/298210868.md)
- [REG - Valereum PLC - Holding(s) in Company](https://longbridge.com/en/news/297943457.md)
- [Some of the Top Biotech Funds Just Bought Into This Under-the-Radar Biotech (NASDAQ: NVCT)](https://longbridge.com/en/news/297912026.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**